Company Information & Drug Savings for Celgene Corporation Medications
Celgene Corporation, now part of Bristol-Myers Squibb, was a biopharmaceutical company focused on cancer and inflammatory disease treatments. Known for Revlimid (lenalidomide) and Pomalyst (pomalidomide) for multiple myeloma, Thalomid for multiple myeloma and leprosy complications, and Otezla (apremilast) for psoriasis and psoriatic arthritis. Celgene’s legacy of hematology and immunology innovation continues through BMS’s oncology leadership.


How to Contact Celgene Corporation
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.




